Dissolved
CVR: 41804505
Not available
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 27 March 2023
CVR · view overview
No headcount reported
Director role ended: Morten Vibe
CVR · 27/03/2023
View the full event history
Kesmalea Therapeutics ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company has been dissolved on 27 March 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorNo. Kesmalea Therapeutics ApS is registered in the Danish CVR register with the status Dissolved and ceased on 27 March 2023.
The CVR number of Kesmalea Therapeutics ApS is 41804505.
Kesmalea Therapeutics ApS was founded on 28 October 2020.
Kesmalea Therapeutics ApS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
Kesmalea Therapeutics ApS was located at c/o Skau Reipurth Advokatpartnerselskab, Amaliegade 37, 1256 København K.
As of March 27, 2023, Taastrup 2024 P/S has stepped down as auditor of Kesmalea Therapeutics ApS.
As of March 27, 2023, Morten Vibe has stepped down as liquidator of Kesmalea Therapeutics ApS.
On March 27, 2023, Kesmalea Therapeutics ApS exited liquidation.
Kesmalea Therapeutics ApS was dissolved on March 27, 2023.
As of October 31, 2022, Morten Vibe is registered as liquidator of Kesmalea Therapeutics ApS.
As of October 31, 2022, Harry Finch has stepped down as director of Kesmalea Therapeutics ApS.
On October 31, 2022, Kesmalea Therapeutics ApS entered liquidation.
Kesmalea Therapeutics ApS has published its interim report for the period October 28, 2020 to December 31, 2021.
As of September 24, 2021, Taastrup 2024 P/S has been appointed auditor of Kesmalea Therapeutics ApS.
As of September 24, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Kesmalea Therapeutics ApS.
As of October 28, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Kesmalea Therapeutics ApS.
As of October 28, 2020, Harry Finch is registered as director of Kesmalea Therapeutics ApS.
Kesmalea Therapeutics ApS was founded on October 28, 2020.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
